Danazol increasingly used.
OA: closed
CC0
⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper analyzes the increasing use of Danazol, a synthetic androgen derivative, highlighting trends and patterns in its prescription and application.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (4)
- Clinical studies with an antigonadotropin-Danazol via openalex
- Danazol Inhibits Steroidogenesis via openalex
- Pituitary gonadotropin inhibitory activity of danazol via openalex
- Pituitary gonadotropin responsiveness with danazol via openalex
Cited by (8)
- The treatment of symptomatic benign breast disease with danazol 1988
- Danazol treatment of advanced prostate cancer: clinical and hormonal effects 1986
- Ultrastructural changes in endometriotic tissue during danazol treatment 1981
- Review: The mechanism of action of danazol, a novel steroid derivative 1980
- Danazol in the treatment of infertility 1980
- Danazol in the treatment of mammary dysplasia 1980
- The treatment of benign breast disease with danazol 1980
- Danazol for benign breast disease 1980
Source provenance
- openalex
- last seen: 2026-05-10T10:10:46.048155+00:00
License: CC0
· commercial use OK